GSK BHR Study (Sont)

Completed · Phase 4 · Has a placebo group

Conditions studied: Asthma

In brief

The purpose of this study was to determine whether asthma control and reduced bronchial hyperresponsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS twice-daily or FP twice-daily in adult and adolescent subjects with persistent asthma

Key facts

Study ID

NCT00920543

Run by

GlaxoSmithKline

People needed

464

Starts

2003-02-01

Expected to finish

2004-10-01

Last updated by the study team

2016-09-01

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Asthma diagnosis
• Controller medications or moderate inhaled corticosteroid dose
• Evidence of reversibility

You may not qualify if…

• Life-threatening asthma
• Asthma instability
• Concurrent respiratory disease
• Drug allergy
• Respiratory tract infection
• Systemic corticosteroid use
• Immunosuppressive medication use
• Positive pregnancy test
• Tobacco use
• Site affiliation

Where it is running

• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Carmichael, California, United States
• GSK Investigational Site — Palmdale, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Jose, California, United States
• GSK Investigational Site — San Jose, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Wheat Ridge, Colorado, United States
• GSK Investigational Site — Hartford, Connecticut, United States
• GSK Investigational Site — Trumbull, Connecticut, United States
• GSK Investigational Site — Bay Pines, Florida, United States
• GSK Investigational Site — Gainesville, Florida, United States
• GSK Investigational Site — Sarasota, Florida, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Normal, Illinois, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Lafayette, Indiana, United States
• GSK Investigational Site — Iowa City, Iowa, United States
• GSK Investigational Site — Louisville, Kentucky, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.